Harvard Health Letter

Ask the doctor: Are there new treatments for COPD?

Two new medications offer hope for people with chronic obstructive pulmonary disease: indacaterol and roflumilast. They can improve lung function and help reduce flare-ups.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In